Tony Kim holds up microfluidic chips with Yom and Sei

Tony Kim holds up microfluidic chips with Yom and Sei

Principal investigator Tony Kim with graduate research assistant Yoshitaka Sei (r.) and research engineer Jiwon Yom (m.) in Kim's lab at Georgia Tech. They are holding microvessel mimicking chips. More advanced versions to be developed in their new NIH-funded project will contain artificial human coronary arteries for research to better understand HDL, or good cholesterol, and why experimental treatments using it to fight atherosclerosis have failed. They hope to optimize HDL cocktails to be effective against the deadly condition that is the foremost cause of coronary artery disease and stroke. Credit: Georgia Tech / Christopher Moore

Additional Information


News Room, Research Horizons

Research, Biotechnology, Health, Bioengineering, Genetics, Life Sciences and Biology, Nanotechnology and Nanoscience
atheroscleroisis, atherosclerosis treatment, HDL, Hdl Cholesterol, HDL-C, Good Cholesterol, CAD, Kidney Ailment, Peripheral Artery Disease, peripheral atherosclerosis, Cardiac Arrest, Clogged Arteries, Hardening Of The Arteries, Stroke, Carotid Artery Disease, carotid artery plaque, Plaque Build Up
  • Created By: Ben Brumfield
  • Workflow Status: Published
  • Created On: Oct 4, 2017 - 5:08pm
  • Last Updated: Oct 5, 2017 - 12:17pm